OBJECTIVES: To perform a systematic functional investigation of different glutathione S-transferase (GST) classes, including GST class Theta (GSTT) member GSTT1-1, in transitional cell carcinoma (TCC) and the surrounding normal uroepithelium of the same individuals. Recently, it was suggested that GSTT1-1 might be an important risk modulator for TCC. METHODS: Tumor samples and surrounding normal uroepithelium were obtained from 24 patients with TCC of urinary bladder. The following substrates with differential specificities were used: 1-chloro-2,4-dinitrobenzene for overall GST activity; 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole for GST Alpha; 1,2-dichloro-4-nitro-benzene for GST Mu; 4-vinylpyridine for GST Pi 1-1(GSTP1-1); and 1,2-epoxy-3-(p-nitrophenoxy)propane for GSTT1-1. RESULTS: GSTP1-1 and GSTT1-1 activities were demonstrated in all uroepithelial and TCC samples, and GST Mu activity was detectable in 11 of 24 patients. In the tumor specimens, significant upregulation of all expressed GST subtypes was observed. The mean GSTP1-1 and GSTT1-1 level in TCC was increased 2-fold and 3.6-fold, respectively, compared with the mean level in the normal uroepithelium (P <0.001). Tumor GSTT1-1 activities correlated statistically significantly with the tumor stage (P <0.05). CONCLUSIONS: In tumors and adjacent normal uroepithelium of patients with TCC, three major cytosolic GST classes, Mu, Pi, and Theta, were expressed. Although the GST isoenzyme pattern in TCC was similar to that of the corresponding normal uroepithelium, during cancer progression a clear tendency toward an increase in all the GST subtypes expressed was noted. For the first time, distinct GSTT1-1 activity levels were demonstrated in human uroepithelium, as well as its pronounced upregulation in TCC.
OBJECTIVES: To perform a systematic functional investigation of different glutathione S-transferase (GST) classes, including GST class Theta (GSTT) member GSTT1-1, in transitional cell carcinoma (TCC) and the surrounding normal uroepithelium of the same individuals. Recently, it was suggested that GSTT1-1 might be an important risk modulator for TCC. METHODS:Tumor samples and surrounding normal uroepithelium were obtained from 24 patients with TCC of urinary bladder. The following substrates with differential specificities were used: 1-chloro-2,4-dinitrobenzene for overall GST activity; 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole for GST Alpha; 1,2-dichloro-4-nitro-benzene for GST Mu; 4-vinylpyridine for GST Pi 1-1(GSTP1-1); and 1,2-epoxy-3-(p-nitrophenoxy)propane for GSTT1-1. RESULTS:GSTP1-1 and GSTT1-1 activities were demonstrated in all uroepithelial and TCC samples, and GST Mu activity was detectable in 11 of 24 patients. In the tumor specimens, significant upregulation of all expressed GST subtypes was observed. The mean GSTP1-1 and GSTT1-1 level in TCC was increased 2-fold and 3.6-fold, respectively, compared with the mean level in the normal uroepithelium (P <0.001). TumorGSTT1-1 activities correlated statistically significantly with the tumor stage (P <0.05). CONCLUSIONS: In tumors and adjacent normal uroepithelium of patients with TCC, three major cytosolic GST classes, Mu, Pi, and Theta, were expressed. Although the GST isoenzyme pattern in TCC was similar to that of the corresponding normal uroepithelium, during cancer progression a clear tendency toward an increase in all the GST subtypes expressed was noted. For the first time, distinct GSTT1-1 activity levels were demonstrated in human uroepithelium, as well as its pronounced upregulation in TCC.
Authors: Caroline F Thorn; Yuan Ji; Richard M Weinshilboum; Russ B Altman; Teri E Klein Journal: Pharmacogenet Genomics Date: 2012-08 Impact factor: 2.089
Authors: Tatjana Djukic; Tatjana Simic; Marija Pljesa-Ercegovac; Marija Matic; Sonja Suvakov; Vesna Coric; Dejan Dragicevic; Ana Savic-Radojevic Journal: Redox Rep Date: 2017-03-13 Impact factor: 4.412
Authors: Tatjana Simic; Ana Savic-Radojevic; Marija Pljesa-Ercegovac; Marija Matic; Jasmina Mimic-Oka Journal: Nat Rev Urol Date: 2009-05 Impact factor: 14.432
Authors: Ana Savic-Radojevic; Tatjana Djukic; Tatjana Simic; Marija Pljesa-Ercegovac; Dejan Dragicevic; Tatjana Pekmezovic; Milica Cekerevac; Veljko Santric; Marija Matic Journal: Redox Rep Date: 2013 Impact factor: 4.412
Authors: Tatjana I Djukic; Ana R Savic-Radojevic; Tatjana D Pekmezovic; Marija G Matic; Marija S Pljesa-Ercegovac; Vesna M Coric; Tanja M Radic; Sonja R Suvakov; Biljana N Krivic; Dejan P Dragicevic; Tatjana P Simic Journal: PLoS One Date: 2013-09-11 Impact factor: 3.240
Authors: Marija G Matic; Vesna M Coric; Ana R Savic-Radojevic; Petar V Bulat; Marija S Pljesa-Ercegovac; Dejan P Dragicevic; Tatjana I Djukic; Tatjana P Simic; Tatjana D Pekmezovic Journal: PLoS One Date: 2014-06-10 Impact factor: 3.240
Authors: Stefanie Hiltbrunner; Michael Mints; Maria Eldh; Robert Rosenblatt; Benny Holmström; Farhood Alamdari; Markus Johansson; Rosanne E Veerman; Ola Winqvist; Amir Sherif; Susanne Gabrielsson Journal: Sci Rep Date: 2020-04-06 Impact factor: 4.379